𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Estimation of individual and population vaccination effectiveness from time-to-event data

✍ Scribed by Michael Haber; Andre Ndikuyeze


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
79 KB
Volume
17
Category
Article
ISSN
0277-6715

No coin nor oath required. For personal study only.

✦ Synopsis


Longini and Halloran and Halloran et al. recently developed a method for estimation of parameters related to the efficacy of a vaccine and to the transmission of an infectious disease from time-to-event (disease or infection) data. This work uses their method to evaluate the individual and population effectiveness of a vaccination programme (Haber et al.). Data from an outbreak of measles in Chad illustrates the new methods.


πŸ“œ SIMILAR VOLUMES


Estimation of Population Vaccination Eff
✍ Michael Haber πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 154 KB

Longini, Datta, and Halloran (1996) proposed to design HIV vaccine trials in a way that will permit the simultaneous estimation of the vaccine effects on susceptibility to infection and on infectiousness of vaccine brak-throughs. The main feature of their design is the inclusion of steady partners o

Estimating relative population sizes fro
✍ Elise Eller πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 319 KB

## Abstract Previous genetic and craniometric studies have suggested greater genetic diversity and a larger effective size in Africa. Several demographic scenarios can explain a larger African effective size, and anthropological geneticists have attempted to obtain better estimates of relative popu

Estimating genetic influence on disease
✍ Gail Gong; Alice S. Whittemore πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 121 KB πŸ‘ 1 views

We describe genetic mixture models and goodness-of-ΓΏt statistics for evaluating the joint e ects of genetic and environmental factors on the risk of chronic diseases. We focus particularly on situations wherein the gene(s) of interest play roles in several diseases, and death due to one disease can

Non-parametric covariance methods for in
✍ Catherine M. Tangen; Gary G. Koch πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 164 KB πŸ‘ 1 views

The principal response criteria for many clinical trials involve time-to-event variables. Usual methods of analysis for this type of response criterion include product-limit estimators of cumulative survival for the treatment groups, (stratified) logrank tests to compare treatments, and proportional